DCT

3:17-cv-11510

Boehringer Ingelheim Pharma Inc v. Teva Pharma USA Inc

General
Filed
11/10/17
Cause of ActionInfringement
SectorBiotech
Status
Closed (07/02/20)
Patent Owner
NPE (W)
Judge
Period
PO Win Rate
--
60%